HDFC Small Cap Fund
The scheme seeks to provide long-term capital appreciation /income by investing predominantly in Small-Cap companies.
Growthvine rating: 3/5 — ranked #17 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹136.22 (as of 2026-11-13) |
|---|
| AUM | ₹40,801 Cr |
|---|
| Expense ratio | 1.30% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Chirag Setalvad |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 12.06% |
|---|
| Sharpe ratio | 0.21 |
|---|
| Standard deviation | 17.84% |
|---|
| Max drawdown | −49.49% |
|---|
| Alpha | -1.92 |
|---|
| Beta | 0.78 |
|---|
Over 5 years, captured 79.8% of NIFTY Smallcap 250's upside and 73.0% of its downside.
Market cap allocation
| Large cap | 7.7% |
|---|
| Mid cap | 10.1% |
|---|
| Small cap | 82.2% |
|---|
Concentration
| Top 5 holdings | 16.7% |
|---|
| Top 10 holdings | 26.9% |
|---|
| Total holdings | 88 |
|---|
| Index overlap | 10.7% |
|---|
| Active share | 89.3% |
|---|
Top holdings
- TREPS - Tri-party Repo — 10.0%
- Firstsource Solutions Ltd. — 4.4%
- Aster DM Healthcare Limited — 3.5%
- Gabriel India Ltd. — 3.4%
- Bank Of Baroda — 2.9%
- eClerx Services Limited — 2.6%
- PVR INOX LIMITED — 2.2%
- Indian Bank — 2.2%
- Krishna Institute of Medical Sciences Limited — 2.0%
- Eris Lifesciences Limited — 1.9%
Top sectors
- Automobile — 11.7%
- Banking & Financial — 10.2%
- Cash — 9.8%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −1.5% | Q4 (Bottom) | #34 of 34 |
| 2025 | −0.6% | Q1 (Top) | #5 of 30 |
| 2024 | 20.4% | Q4 (Bottom) | #24 of 28 |
| 2023 | 44.8% | Q2 | #10 of 24 |
| 2022 | 4.6% | Q2 | #7 of 22 |